Review Shows Obesity Drugs, Surgery Lead to Higher Fat-Free Mass Loss

A systematic review finds that obesity drugs and surgery result in greater fat-free mass loss compared to diet and exercise interventions among individuals losing at least 10% of their body weight.

A new systematic review presented at the European Congress on Obesity highlights a concerning trend regarding weight loss strategies. The study, conducted by Professor Signe Torekov and Lærke Bruun Madsen from the University of Copenhagen, reveals that while diet and exercise interventions are effective in reducing overall weight, they result in a lower proportion of fat-free mass loss compared to obesity surgery or certain obesity drugs.

Traditionally, weight reduction has relied on behavioral interventions such as diet and exercise. However, these methods often require sustained adherence and significant lifestyle changes. In recent years, the introduction of incretin-based drugs for obesity has provided an alternative approach that can lead to substantial weight loss but raises concerns about potential losses in fat-free mass.

The review examined 21 studies involving a total of 1,334 participants who achieved at least a 10% reduction in body weight through various interventions. The studies included randomized controlled trials published between 2015 and October 2025 that measured changes in fat-free mass using dual-energy X-ray absorptiometry (DXA) or magnetic resonance imaging (MRI).

Key findings from the review include: Diet and exercise interventions resulted in a mean loss of -1.80 kg of fat-free mass. Incretin-based obesity drug therapies, when compared to placebo, led to a mean loss of -4.75 kg of fat-free mass. Obesity surgery interventions were associated with the greatest reduction in fat-free mass at -9.14 kg.

The proportion of total weight loss attributable to fat-free mass was also analyzed: Diet and exercise interventions resulted in 14.3% of total weight loss from fat-free mass. Incretin-based obesity drug therapies led to a 31.5% reduction, while obesity surgery interventions caused a 32.9% reduction.

The authors emphasize the importance of preserving fat-free mass during weight loss, as muscle and organ tissues have a higher metabolic rate compared to fat mass, which supports metabolism and aids in sustained weight loss. Losses in fat-free mass can negatively impact physical function and metabolic health.

Dr. Lærke Bruun Madsen, one of the study's authors, stated, "These findings underscore the importance of incorporating strategies aimed at preserving fat-free mass, particularly structured exercise across all weight-loss approaches." The review underscores that while diet and exercise are effective in reducing overall body weight, they may not be as beneficial for maintaining muscle and bone mass. In contrast, obesity surgery and certain drugs can lead to significant losses in fat-free mass.

This systematic analysis provides valuable insights into the comparative benefits of different weight loss strategies, highlighting the need for clinicians to consider both the efficacy and potential side effects when recommending treatment options. Future research should focus on developing interventions that optimize fat loss while preserving essential body tissues.